Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii - PubMed (original) (raw)

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii

L E Neyer et al. Infect Immun. 1997 May.

Abstract

Interleukin-10 (IL-10) is a cytokine which can inhibit T-cell and natural killer (NK) cell functions associated with cell-mediated immunity to intracellular infections. The production of IL-10 by mice infected with Toxoplasma gondii has been implicated in the suppression of lymphocyte proliferation observed during acute toxoplasmosis, as well as susceptibility to infection with this parasite. We have used C57BL/6 mice which lack a functional IL-10 gene (IL-10(-/-) mice) to investigate the role of IL-10 in acute toxoplasmosis. Intraperitoneal infection of IL-10(-/-) mice with T. gondii resulted in 100% mortality by day 13, whereas wild-type C57BL/6 (WT) mice survived acute infection. IL-10(-/-) mice infected with T. gondii had significantly higher serum levels of IL-12 and gamma interferon (IFN-gamma) than WT mice. Early mortality of infected IL-10(-/-) mice was prevented by treatment with IL-10 and significantly delayed by neutralizing antibodies to IL-12 and IFN-gamma. Further studies revealed that SCID/IL-10(-/-) mice infected with T. gondii had delayed time to death compared to IL-10(-/-) mice, indicating that lymphocytes contributed to death of IL-10(-/-) mice. In addition, infected SCID/IL-10(-/-) mice survived longer than infected SCID mice. These latter data indicate that in mice lacking lymphocytes, endogenous IL-10 is associated with increased susceptibility to T. gondii. However, the lack of IL-10 does not alter the infection-induced suppression of T cell and NK cell functions. Our experiments reveal that IL-10 is associated with protection or increased susceptibility to infection with T. gondii, depending on whether mice possess lymphocytes, and demonstrate the important roles of IL-12 and IFN-gamma in the early infection-induced mortality observed in the IL-10(-/-) mice.

PubMed Disclaimer

Cited by

Mineralization Reduces the Toxicity and Improves Stability and Protective Immune Response Induced by Toxoplasma gondii.
Li L, Guan YC, Bai SY, Jin QW, Tao JP, Zhu GD, Huang SY. Li L, et al. Vaccines (Basel). 2023 Dec 28;12(1):35. doi: 10.3390/vaccines12010035. Vaccines (Basel). 2023. PMID: 38250848 Free PMC article.
Vaccination with Toxoplasma lysate antigen or its encapsulated niosomes form immunomodulates adjuvant-induced arthritis through JAK3 downregulation.
Hassouna SS, Allam EA, Sheta E, Khodear GAM, Khedr MI, Khedr SI, Gomaa MM. Hassouna SS, et al. Inflammopharmacology. 2023 Dec;31(6):3101-3114. doi: 10.1007/s10787-023-01267-0. Epub 2023 Jun 30. Inflammopharmacology. 2023. PMID: 37389660 Free PMC article.
Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.
Sana M, Rashid M, Rashid I, Akbar H, Gomez-Marin JE, Dimier-Poisson I. Sana M, et al. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221078436. doi: 10.1177/03946320221078436. Int J Immunopathol Pharmacol. 2022. PMID: 35227108 Free PMC article. Review.
Interleukin-27 in Tuberculosis: A Sheep in Wolf's Clothing?
Ritter K, Rousseau J, Hölscher C. Ritter K, et al. Front Immunol. 2022 Jan 18;12:810602. doi: 10.3389/fimmu.2021.810602. eCollection 2021. Front Immunol. 2022. PMID: 35116036 Free PMC article. Review.

References

1. Cell Immunol. 1986 Apr 1;98(2):422-33 - PubMed
1. J Clin Invest. 1996 Aug 15;98(4):1010-20 - PubMed
1. Science. 1988 Apr 22;240(4851):516-8 - PubMed
1. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7011-5 - PubMed
1. J Exp Med. 1992 Jan 1;175(1):169-74 - PubMed

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii - PubMed (original) (raw)